Ritonavir loaded solid lipid nanoparticles for oral drug delivery and bioavailability enhancement
Abstract Background Ritonavir is an anti-retroviral protease inhibitor to treat HIV, AIDS infections. Methods The RN-SLNs were prepared by using hot homogenization followed ultrasonication method and optimized by using a two-factor, three-level central composte design (CCD). The independent variable...
Saved in:
Main Authors: | Ananda Kumar Chettupalli, Sarad Pawar Naik Bukke, Shaik Abdul Rahaman, Aziz Unnisa, Madhumitha Adepu, Marati Kavitha, Molakpogu Ravindra Babu, Bayapa Reddy Narapureddy, Hope Onohuean |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2025-01-01
|
Series: | Discover Applied Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1007/s42452-024-06322-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of quercetin on the transport of ritonavir to the central nervous system in vitro and in vivo
by: Liang Gongwen, et al.
Published: (2016-03-01) -
Comparative efficacy of repurposed drugs lopinavir-ritonavir and darunavir-ritonavir in hospitalised COVID-19 patients: insights from a tertiary centre cohort
by: Dóra Paróczai, et al.
Published: (2025-01-01) -
Stability indicating RP-HPLC technique for simultaneous estimation of nirmatrelvir and ritonavir in their new copackaged dosage form for COVID-19 treatment
by: Mohamed G. Yassin, et al.
Published: (2025-01-01) -
Bioavailability study of enantiopure (S)-Equol in CD(SD)IGS rats
by: Seethakallu Ramachandraiah AnandaKumar, et al.
Published: (2025-01-01) -
Persistent hepatocyte secretory failure in lopinavir/ritonavir related to drug-induced liver injury: a case report
by: Yue Sun, et al.
Published: (2025-02-01)